U.S. Imposes 26% Tariff on Indian Imports, Spares Pharma Sector
The U.S. has imposed a 26% tariff on imports from India, dealing a blow to New Delhi's hopes for leniency under President Donald Trump’s global trade policies. A baseline 10% tariff begins Saturday, with the full rate effective April 9. Trump cited India's 52% tariffs on U.S. goods as justification, calling the move a reciprocal measure. India now faces new challenges in sectors like electronics and gems and jewellery, which represent nearly $23 billion in exports. However, the U.S. exempted Indian pharmaceutical exports—worth around $9 billion annually—providing relief to the...


